Y28-27320-95340
3 vaccinations
5 coded responses
29 check-ins
5 free-text entries
1 call case
- Sex
- —
- Age at first dose
- 41-45
- ZIP prefix
- 220 / VA
- Registered
- 2021-01-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-18
Dose 1 — Moderna
-
2021-01-19
Registered in v-safe
-
2021-01-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-20
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-08
-
2021-02-15
Dose 2 — Moderna
- 2021-02-22
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-05-17
- 2021-08-16
-
2021-10-23
Dose 3 — Moderna
-
2021-10-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-27
- 2021-10-28
- 2021-10-29
-
2021-10-30
Health check-in — day 7, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-06
- 2021-11-13
-
2021-11-20
Survey response — day 28, dose 3MedDRA: Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Signifficant tirednessMedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Survey response — day 35, dose 3MedDRA: Arthralgia — Feeling: Good · Be unable to do your normal daily activitiesFree text: Unexplained joint painMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Survey response — day 42, dose 3MedDRA: Arthralgia — Feeling: GoodFree text: Continued unexplained joint pain.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-22
-
2022-04-23
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Be unable to work or attend schoolFree text: Sinus infection and respiratory coldMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Survey response — 12 months, dose 3MedDRA: Nasopharyngitis, Sinusitis — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cold & sinus infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-10-23
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-10-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-18 | Moderna | |
| 2 | 2021-02-15 | Moderna | |
| 3 | 2021-10-23 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-10-23 | Unsuccessful |
Free text
Release 10 — day 28, dose 3
Symptoms: Signifficant tiredness
Release 10 — day 35, dose 3
Symptoms: Unexplained joint pain
Release 10 — day 42, dose 3
Symptoms: Continued unexplained joint pain.
Release 11 — 6 months, dose 3
Symptoms: Sinus infection and respiratory cold
Release 12 — 12 months, dose 3
Symptoms: Cold & sinus infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release